V. I. Rasaiah

Direct injection of kit ligand-2 lentivirus improves cardiac repair and rescues mice post-myocardial infarction.

C. Tei, J. Medin, Takeya Sato, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Tumor protection following vaccination with low doses of lentivirally transduced DCs expressing the self-antigen erbB2.

J. Medin, J. Bramson, R. Head, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Treatment of neutral glycosphingolipid lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1

J. Medin, B. Binnington, C. Lingwood, 2006, The FEBS journal.

Multiple reduced-intensity conditioning regimens facilitate correction of Fabry mice after transplantation of transduced cells.

A. Poeppl, J. Medin, S. Liang, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Implementation of high-throughput screening for Fabry disease in Toronto dialysis patients

J. Medin, D. Oreopoulos, V. I. Rasaiah, 2008, NDT plus.

α-Galactosidase A-Tat Fusion Enhances Storage Reduction in Hearts and Kidneys of Fabry Mice

C. Tei, J. Medin, K. Higuchi, 2010, Molecular medicine.

Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors.

A. Poeppl, R. Brady, J. Medin, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem/progenitor cells

G J Murray, R. Brady, J. Medin, 2007, Gene Therapy.

Correction of cardiac abnormalities in fabry mice by direct intraventricular injection of a recombinant lentiviral vector that engineers expression of alpha-galactosidase A.

J. Medin, K. Higuchi, Peter P. Liu, 2006, Circulation journal : official journal of the Japanese Circulation Society.